Anti-Candida activity of YH-1715R, a new triazole derivative

Journal of Microbiology and Biotechnology

Volumn 14, Issue 4, 2004, Pages 693-697

  Park, Kang Sik ^b   Kang, Heui Il ^a   Lee, Jong Wook ^a   Paik, Young Ki ^b  

^a Yuhan Corporation   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

14 demethylase; Candida albicans; Ergosterol biosynthesis; Triazole; YH 1715R

Indexed keywords

2 (2,4 DIFLUOROPHENYL) 3 (3 METHOXY 1,2,4 ISOTHIAZOL 3 YLTHIO) 1 (1H 1,2,4 TRIAZOL 1 YL) 2 BUTANOL; ERGOSTEROL; FLUCONAZOLE; LANOSTEROL DERIVATIVE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; YH 1715R;

ANTIFUNGAL ACTIVITY; ARTICLE; BIOSYNTHESIS; CANDIDA ALBICANS; CELL FREE SYSTEM; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; FUNGAL CELL; GAS LIQUID CHROMATOGRAPHY; IC 50; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STRUCTURE ANALYSIS;

CANDIDA; CANDIDA ALBICANS;

EID: 4444311815     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Groll, A. H. and T. J. Walsh. 2001. Uncommon opportunistic fungi: New nosocomial threats. Clin. Microbiol. Infect. 7: 8-24.
2. Hitchcock, C. A., K. Dickinson, S. B. Brown, E. G. V. Evans, and D. J. Adams. 1990. Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14α-sterol demethylase purified from Candida albicans. Biochem. J. 266: 475-480.
3. Kang, H.-I. and J. W. Lee. Korea Patent Application: KP 94-4918.
4. Lamb, D. C., D. E. Kelly, B. C. Baldwin, F. Gozzo, P. Boscott, W. G. Richards, and S. L. Kelly. 1997. Differential inhibition of Candida albicans CYP51 by stereoisomers of azole antifungals. FEMS Microbiol. Lett. 149: 23-30.
5. Lee, E. Y., D. M. Lim, S. E. Yoo, D. K. Kim, and Y.-K. Paik. 1999. Biochemical basis for a cholesterol-lowering activity of 2-[2″-(1″,3″-dioxolane)]-2-methyl-4-(2′ -oxo-1′-pyrrolidinyl)-6- nitro-2H-1-benzopyran (SKP-450), a novel antihypertensive agent. Biochem. Pharmacol. 57: 579-582.
6. National Committee for Clinical Laboratory Standards. 1997. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts - Approved Standard M27-A. NCCLS, Villanova, PA, U.S.A.
7. Niwano, Y., H. Koga, K. Kodama, K. Kanai, T. Miyazaki, and H. Yamaguchi. 1999. Inhibition of sterol 14 α-demethylation of Candida albicans with NND-502, a novel optically active imidazole antimycotic agent. Med. Mycol. 37: 351-355.
8. Park, K.-S., K.-C. Kang, J.-H. Kim, D. J. Adams, T.-N. Johng, and Y.-K. Paik. 1999. Differential inhibitory effects of protoberberines on sterol and chitin biosyntheses in Candida albicans. J. Antimicrob. Chemother. 43: 667-674.
9. Park, K.-S., K.-C. Kang, K.-Y. Kim, P.-Y. Jeong, J.-H. Kim, D. J. Adams, J.-H. Kim, and Y.-K. Paik. 2001. HWY-289, a novel semi-synthetic protoberberine derivative with multiple target sites in Candida albicans. J. Antimicrob. Chemother. 47: 513-519.
10. Sanglard, D. F. and C. Odds. 2002. Resistance of Candida species to antifungal agents: Molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2: 73-85.
11. Vanden Bossche, H. and L. Koymans. 1998. Cytochromes P450 in fungi. Mycoses 41: 32-38.
12. Yoshida, Y. and Y. Aoyama. 1987. Interaction of azole antifungal agents with cytochrome P45014DM purified from Saccharomyces cerevisiae microsomes. Biochem. Pharmacol. 36: 229-235.